|
ELUCIDATING CUTANEOUS MECHANOSENSORY CIRCUITS, FROM DEVELOPMENT TO DISEASE |
5R35NS097344-04 |
GINTY, DAVID D |
NINDS |
2019 |
|
STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE |
5R35NS105078-02 |
LUPSKI, JAMES R. |
NINDS |
2019 |
|
ROLE OF SCN1B IN INHERITED EPILEPSY |
5R37NS076752-07 |
ISOM, LORI L. |
NINDS |
2019 |
|
PRECLINICAL TESTING OF SPLICE MODULATING OLIGONUCLEOTIDES TARGETING SCN8A TO TREAT DRAVET SYNDROME |
5R43NS105291-02 |
TALLENT, MELANIE K |
NINDS |
2019 |
|
PIVOTAL TRIAL OF VAMOROLONE IN DUCHENNE MUSCULAR DYSTROPHY |
5R44NS095423-04 |
HOFFMAN, ERIC P. |
NINDS |
2019 |
|
TRAINING PROGRAM IN NEURODEVELOPMENTAL DISABILITIES |
5T32NS007413-22 |
ROBINSON, MICHAEL BYRNE |
NINDS |
2019 |
|
BIOSTATISTICS AND DATA MANAGEMENT FOR A TRIAL OF CORTICOSTEROID REGIMENS IN DMD |
5U01NS061795-09 |
MCDERMOTT, MICHAEL P |
NINDS |
2019 |
|
FOR-DMD: DOUBLE-BLIND RANDOMIZED TRIAL TO OPTIMIZE STEROID REGIMEN IN DUCHENNE MD |
5U01NS061799-09 |
GRIGGS, ROBERT C |
NINDS |
2019 |
|
PREVENTING EPILEPSY USING VIGABATRIN IN INFANTS WITH TUBEROUS SCLEROSIS COMPLEX |
5U01NS092595-04 |
BEBIN, MARTINA |
NINDS |
2019 |
|
HIGH-DOSE ERYTHROPOIETIN FOR ASPHYXIA AND ENCEPHALOPATHY (HEAL) CCC |
5U01NS092764-04 |
WU, YVONNE W |
NINDS |
2019 |